Please login to the form below

Not currently logged in
Email:
Password:

Almac Group appoints two new vice presidents

Dr John Robson and George Tiger join the team

Global contract development and manufacturing organisation Almac Group gas appointed Dr John Robson and George Tiger as vice presidents.

Robson joins as VP of quality operations at its Sciences' business unit based in the UK. He will hold responsibility for the operations of the analytical services business and overseeing quality across the firm's location in the UK and US.

Robson has over two decades of experience in business leadership, quality and analytical roles. He joins from Lonza Biologics, where he held the position of global head of analytical services.

Dr Stephen Barr, managing director of Almac's Sciences business unit, said: “John has an impressive track record and will bring a wealth of industry experience to the existing Management team. We are delighted to have him join us.” 

Tiger has been named as VP of global business development at Almac's Clinical Technologies, based in the US. In the role, he will be responsible for commercial operations and business development.

He joins from Health Market Science, where he held the position of senior VP of life sciences sales. Prior to this, he spent over 12 years at ERT, a supplier of cardiac safety, respiratory and eCOA solutions, where her served in a series of management positions globally.

Jim Murphy, managing director of Almac's Clinical Technologies business unit, commented: “We are pleased to welcome George to Almac. He clearly brings an impressive track record, which is especially important to us as we continue to drive global sales and advance our integrated solutions across the Almac Group. 

“With his expertise and level of experience he will prove to be a great asset to the senior management team.”

9th July 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics